AGTR1 and hypertensive disorder: One-hundred forty-six hospitalized COVID-19 patients with hypertension were investigated, including 48 patients who took AT1R blockers for hypertension treatment (AT1RB group) and 98 patients who took other antihypertensive medications (Non-AT1RB group) before admission.